PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Greater availability of neurosurgeons could reduce risk of death from motor vehicle accidents

2012-07-25
(Press-News.org) Charlottesville, VA (July 24, 2012). Researchers at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire have found an association between increasing the distribution of neurosurgeons throughout the United States and decreasing the risk of death from motor vehicle accidents (MVAs). The findings of their study are described in the article "Increased population density of neurosurgeons associated with decreased risk of death from MVAs in the United States. Clinical article," by Atman Desai, M.D., and colleagues, published today online, ahead of print, in the Journal of Neurosurgery.

The researchers reviewed some basics about MVAs, the leading cause of death in the United States among young persons (1 to 34 years of age). The primary cause of death arising from MVAs is traumatic brain injury, whose treatment is generally handled by neurosurgeons. Motor vehicle accidents are more likely to result in fatalities in rural settings, which some attribute to a slow medical response time and reduced access to trauma resources. For the most part, neurosurgeons are clustered in and around cities that house tertiary care hospitals, and thus there is an uneven distribution of this specialty throughout the US. Bearing these facts in mind, the authors hypothesized that an increased population density of neurosurgeons would decrease the risk of death from an MVA.

Desai and colleagues performed a retrospective analysis of data from the Area Resource File (2009�), a database containing county-level information on health care facilities and their utilization and expenditures; health care professionals and their training; and socioeconomic and environmental characteristics. Data from 3141 US counties were analyzed; 2051 of these counties were classified as rural. The primary outcome variable was the average number of deaths due to MVAs per million population for each county during the 3-year period 2004 through 2006.The primary independent variable was the density of neurosurgeons (number of neurosurgeons per million population) in 2006.

In the 3141 US counties that were examined, the mean number of MVA-related deaths per million persons was 226. The average number of neurosurgeons per county was six. The greatest number of neurosurgeons in a county was 372; most counties had none. In an unadjusted analysis, the authors found that an increase of one neurosurgeon per million population was associated with 1.9 fewer deaths due to MVAs per million population.

In a multivariate analysis, in which adjustments were made for county urbanicity, socioeconomic conditions, and density of general practitioners, an increase of one neurosurgeon was associated with 1.01 fewer deaths from MVAs per million population. This association was present regardless of whether the county was rural or urban. When Desai and colleagues compared the association between deaths from MVAs and the distribution of other medical specialties, the researchers found that an equivalent decrease in MVA-related deaths (one fewer death) would require an addition of 33 primary care providers; according to another study, an addition of 6 general surgeons per million population would be needed for the same affect. Rural setting, persistent poverty, and low level of education were all associated with significant increases in MVA-related deaths.

Given the association found between the distribution of neurosurgeons and MVA-related deaths, Desai and colleagues conclude that the availability of local neurosurgeons may be important for the overall likelihood of surviving an MVA, and thus neurosurgical education and practice throughout the US should be promoted.

### Desai A, Bekelis K, Zhao W., Ball PA: "Increased population density of neurosurgeons associated with decreased risk of death from MVAs in the United States. Clinical Article." Journal of Neurosurgery, published ahead of print July 24, 2012; DOI: 10.3171/2012.6.JNS111281.

Disclosure: The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

For 68 years, the Journal of Neurosurgery has been recognized by neurosurgeons and other medical specialists the world over for its authoritative, clinical articles, cutting-edge laboratory research papers, renowned case reports, expert technical notes, and more. Each article is rigorously peer reviewed. The Journal of Neurosurgery is published monthly by the JNS Publishing Group, the scholarly journal division of the American Association of Neurological Surgeons (http://www.aans.org), an association dedicated to advancing the specialty of neurological surgery in order to promote the highest quality of patient care. The Journal of Neurosurgery appears in print and on the Internet (http://www.thejns.org).


ELSE PRESS RELEASES FROM THIS DATE:

Some harmful effects of light at night can be reversed

2012-07-25
COLUMBUS, Ohio -- Chronic exposure to dim light at night can lead to depressive symptoms in rodents -- but these negative effects can be reversed simply by returning to a standard light-dark cycle, a new study suggests. While hamsters exposed to light at night for four weeks showed evidence of depressive symptoms, those symptoms essentially disappeared after about two weeks if they returned to normal lighting conditions. Even changes in the brain that occurred after hamsters lived with chronic light at night reversed themselves after returning to a more normal light ...

A quarter of our very elderly have undiagnosed treatable heart problems, research reveals

2012-07-25
The very oldest in our society are missing out on simple heart treatments which can prolong and improve their quality of life, Newcastle heart experts say. Studying a group of people aged 87 to 89 years old, the team of researchers at Newcastle University found that a routine test in the home revealed that around a quarter of them had undiagnosed heart problems which could be treated with established and cost-effective treatments. In the study, funded by the British Heart Foundation (BHF), the team visited the homes of 376 people aged 87 to 89 years old and carried ...

Physicists study the classics for hidden truths

2012-07-25
The truth behind some of the world's most famous historical myths, including Homer's epic, the Iliad, has been bolstered by two researchers who have analysed the relationships between the myths' characters and compared them to real-life social networks. In a study published online today, 25 July, in the journal EPL (Europhysics Letters), Pádraig Mac Carron and Ralph Kenna from Coventry University performed detailed text analyses of the Iliad, the English poem, Beowulf, and the Irish epic, the Táin Bó Cuailnge. They found that the interactions between the characters ...

Lace plants explain programmed cell death

2012-07-25
Programmed cell death (PCD) is a highly regulated process that occurs in all animals and plants as part of normal development and in response to the environment. New research published in BioMed Central's open access journal BMC Plant Biology is the first to document the physiological events in the lace plant (Aponogeton madagascariensis) which occur via PCD to produce the characteristic holes in its leaves. The aquatic lace plant, endemic to Madagascar, uses PCD to generate holes in its leaves. Researchers from Dalhousie University, Nova Scotia, used long-term live ...

Use of sunbeds leads to 3000+ cases of melanoma a year in Europe and 'tougher actions' are needed

2012-07-25
Of 63,942 new cases of cutaneous melanoma (a form of skin cancer) diagnosed each year in Europe an estimated 3,438 (5.4%) are related to sunbed use. Sunbed users are at a 20% increased relative risk of skin cancer compared with those who have never used a sunbed. This risk doubles if they start before the age of 35 and experts warn that "tougher actions" are needed to reduce this risk. Sun exposure is the most significant environmental cause of skin cancer and sunbeds have become the main non-solar source of UV exposure in Western Europe (UV is the wavelength associated ...

Concerns over accuracy of tools to predict risk of repeat offending

2012-07-25
Research: Use of risk assessment instruments to predict violence and antisocial behaviour in 73 samples involving 24,827 people: systematic review and meta-analysis Tools designed to predict an individual's risk of repeat offending are not sufficient on their own to inform sentencing and release or discharge decisions, concludes a study published on bmj.com today. Although they appear to identify low risk individuals with high levels of accuracy, the authors say "their use as sole determinants of detention, sentencing, and release is not supported by the current evidence." Risk ...

Study reveals substantial misdiagnosis of malaria in parts of Asia

2012-07-25
Research: Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study Substantial overdiagnosis and mistreatment of malaria is evident in south and central Asia, warns a study published on bmj.com today. With more than two billion people at risk of malaria in this part of Asia – larger than that of Africa - this is a major public health problem which needs to be confronted, say the authors. Malaria remains one of the most important infectious diseases of poverty. Recent global malaria treatment ...

New drug could treat Alzheimer's, multiple sclerosis and brain injury

2012-07-25
CHICAGO --- A new class of drug developed at Northwestern University Feinberg School of Medicine shows early promise of being a one-size-fits-all therapy for Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain. Northwestern has recently been issued patents to cover this new drug class and has licensed the commercial development to a biotech company that has recently completed the first human Phase 1 clinical trial for the drug. The drugs in this class target a particular type of brain inflammation, ...

New research determines how a single brain trauma may lead to Alzheimer's disease

2012-07-25
BOSTON (July 24, 2012, 5:00PM EST)—A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer's disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer's. The paper, published in The Journal of Neuroscience, identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme, BACE1, in the brain. These results may lead to the development of a drug treatment that targets this mechanism to slow ...

New publication examines effect of early drug administration on Alzheimer's animal model

2012-07-25
LEXINGTON, Ky. (July 25, 2012) — In a study published June 25 in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, and D. Martin Watterson of the Northwestern University Feinberg School of Medicine, present results showing that a new central nervous system drug compound can reduce Alzheimer's pathology in a mouse model of the disease. The drug, called MW-151, is a selective suppressor of brain inflammation and overproduction of proinflammatory molecules from glial ...

LAST 30 PRESS RELEASES:

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

[Press-News.org] Greater availability of neurosurgeons could reduce risk of death from motor vehicle accidents